Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
224.9 USD | +1.48% |
|
-2.04% | -13.29% |
05:28pm | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
03:00pm | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.29% | 32.26B | |
+7.40% | 101B | |
+8.42% | 42.18B | |
+80.80% | 29.79B | |
-11.23% | 16.06B | |
+2.03% | 14.45B | |
-6.77% | 12.01B | |
+177.16% | 10.71B | |
+4.12% | 8.89B | |
-56.13% | 8.83B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says